0001104659-19-047287.txt : 20190826 0001104659-19-047287.hdr.sgml : 20190826 20190826161848 ACCESSION NUMBER: 0001104659-19-047287 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190822 FILED AS OF DATE: 20190826 DATE AS OF CHANGE: 20190826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wedell-Wedellsborg Johan CENTRAL INDEX KEY: 0001753185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 191053161 MAIL ADDRESS: STREET 1: RUNGSTED STRANDVEJ 113 CITY: RUNGSTED KYST STATE: G7 ZIP: 2960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4 1 a4.xml 4 X0306 4 2019-08-22 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001753185 Wedell-Wedellsborg Johan C/O WECO GROUP A/S RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960 DENMARK 1 0 1 0 Common Stock 2019-08-22 4 S 0 990 27.75 D 654158 I By Weco Group A/S Reporting Person is the majority owner of Weco Group A/S and as such has sole voting and dispositive power with respect to such shares. /s/ Johan Wedell-Wedellsborg 2019-08-26